Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AT-02 by Attralus for Primary Systemic Amyloidosis: Likelihood of Approval
AT-02 is under clinical development by Attralus and currently in Phase I for Primary Systemic Amyloidosis. According to GlobalData, Phase...